Programmable proteins designed with Boolean logic gates may improve targeted drug delivery precision and scalability, researchers report.

As evidence grew this spring that the drug remdesivir was helping COVID-19 patients, some Wall Street investors bet on analysts’ estimates that its maker, Gilead Sciences Inc , could charge up to $10, ...